Saba Noor

Dr. Saba Noor currently serves as a DHR-Young Scientist at the Centre for Interdisciplinary Research in Basic Sciences (CIRBSc), Jamia Millia Islamia (JMI), New Delhi, India. Her research is centered on the structure-guided design and development of human Aurora kinase inhibitors for the therapeutic treatment of lung cancer. She possesses extensive expertise in protein biology, molecular biology, and rational drug design. Dr. Noor earned her Ph.D. from Aligarh Muslim University and has received prestigious research grants from the Department of Health Research (DHR) and the Council of Scientific and Industrial Research (CSIR). She has actively presented her work at multiple international scientific forums with support from the Government of India. In addition to numerous peer-reviewed publications, she is the editor of the recently published Elsevier book titled "Protein Kinase Inhibitors: From Discovery to Therapeutics”.

Publications:

1. Noor S, Choudhury, Islam KU, Yousuf M, Raza A, Ansari, Ashraf A, Hussain A, Hassan MI. Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B. Journal of Molecular and Cellular Biochemistry 2024 Jun 3 (Impact factor: 4.3)

2. Noor S, Choudhury A, Raza A, Ashraf A, Islam KU, Imtiyaz K, Islam A, Hassan MI. Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy. International Journal of Biological Macromolecules, Feb;258(Pt 1):128813. (Impact factor: 7.7)

3. Noor S, Mohammad T, Rub MA, Raza A, Azum N, Yadav DK, Hassan MI, Abdullah M. Asiri. Biomedical Features and Therapeutic Potential of Rosmarinic Acid, 2022. Archives of Pharmacal Research, 45(4):205-228. doi: 10.1007/s12272-022-01378-2 (Impact factor: 6.9)